JP2020045368A - Oral composition for improving juvenile learning ability, and functional food, and method for improving juvenile learning ability - Google Patents

Oral composition for improving juvenile learning ability, and functional food, and method for improving juvenile learning ability Download PDF

Info

Publication number
JP2020045368A
JP2020045368A JP2019230367A JP2019230367A JP2020045368A JP 2020045368 A JP2020045368 A JP 2020045368A JP 2019230367 A JP2019230367 A JP 2019230367A JP 2019230367 A JP2019230367 A JP 2019230367A JP 2020045368 A JP2020045368 A JP 2020045368A
Authority
JP
Japan
Prior art keywords
oral composition
ingestion
test
learning ability
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019230367A
Other languages
Japanese (ja)
Other versions
JP7383281B2 (en
Inventor
昭宏 岡本
Akihiro Okamoto
昭宏 岡本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ongane Japan Co Ltd
Original Assignee
Ongane Japan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2018115554A external-priority patent/JP2019218284A/en
Application filed by Ongane Japan Co Ltd filed Critical Ongane Japan Co Ltd
Priority to JP2019230367A priority Critical patent/JP7383281B2/en
Publication of JP2020045368A publication Critical patent/JP2020045368A/en
Application granted granted Critical
Publication of JP7383281B2 publication Critical patent/JP7383281B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

To provide an oral composition having the effect of improving a juvenile learning ability.SOLUTION: An oral composition for improving a juvenile learning ability contains a processed product of at least one site selected from the rhizome, leaf part and stem part of Panax ginseng. The processed product is preferably a ground product or extract of a dried product of steamed rhizome.SELECTED DRAWING: None

Description

本発明は、若齢者の脳機能を改善させる作用を有し、学習能力向上に寄与する組成物に関する。   The present invention relates to a composition having an effect of improving brain function of a young person and contributing to improvement of learning ability.

高齢者社会に伴い、認知症患者が急増しており、脳機能改善作用を有する物質の探索が盛んに行われている。
高麗人参(朝鮮人参)抽出物においても、脳機能改善作用について報告されている。例えば、特許文献1には朝鮮人参の実抽出物を有効成分として含む脳活性化用組成物が開示されている。また、特許文献2にはニンジン抽出物、イチョウ葉抽出物、サフラン柱頭の抽出物、ダイズ抽出物を配合した虚血性の脳血管疾患および老年痴呆を処置するための漢方薬組成物が開示されている。また、特許文献3には人参由来の糖リポタンパク質ジントニンを有効成分として含む学習能力向上および記憶増進用薬学組成物が開示されている。また、特許文献4には人参由来のジンセノサイドRg3薬用組成物水溶液を記憶改善に使用する薬剤に使用することが開示されている。
With the aging society, the number of dementia patients is increasing rapidly, and the search for substances having a cerebral function improving effect is being actively conducted.
Ginseng (Korean ginseng) extract has also been reported to improve brain function. For example, Patent Document 1 discloses a brain-activating composition containing a ginseng berry extract as an active ingredient. Patent Document 2 discloses a herbal composition for treating ischemic cerebrovascular disease and senile dementia, which contains a carrot extract, a ginkgo leaf extract, an extract of saffron stigma, and a soybean extract. . Patent Literature 3 discloses a pharmaceutical composition for improving learning ability and improving memory, which contains ginseng-derived sugar lipoprotein gintonin as an active ingredient. Patent Literature 4 discloses that an aqueous solution of a ginsenoside Rg3 medicinal composition derived from ginseng is used as a drug for improving memory.

特表2016−515611号公報JP-T-2006-516611A 特開2012−214500号公報JP 2012-214500 A 特表2014−532048号公報JP 2014-532048 A 特許第5525814号公報Japanese Patent No. 5525814

一方、近年、高齢者ではなく、10代の若齢者においても、脳機能を改善し、学習能力や記憶力を増強することが望まれている。
しかしながら、従来の脳機能改善作用を有するとされている物質は、高齢者の認知症の予防、改善を対象としているものが多く、認知症等を改善する効果があったとしても、脳の発育期である若齢者に対しても脳機能改善作用を示すか否かについての詳細は不明であるのが実情である。特許文献1〜4で開示された高麗人参抽出物においても、若齢者に対して脳機能改善作用を示すか否かについて評価されてはいない。
On the other hand, in recent years, it has been desired to improve brain function and enhance learning ability and memory ability not only for the elderly but also for teenagers.
However, many of the substances known to have an effect of improving brain function are aimed at preventing and improving dementia in the elderly, and even if they have the effect of improving dementia, etc. The fact is that it is unclear whether or not a young person who is in a childhood has a cerebral function improving effect. The ginseng extract disclosed in Patent Documents 1 to 4 has not been evaluated as to whether or not it shows a cerebral function improving effect on young people.

かかる状況下、本発明の目的は、若齢者の学習能力向上効果を有する経口組成物を提供することである。   Under such circumstances, an object of the present invention is to provide an oral composition having an effect of improving the learning ability of young people.

本発明者は、上記課題を解決すべく鋭意研究を重ねた結果、下記の発明が上記目的に合致することを見出し、本発明に至った   The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that the following inventions meet the above objects, and have reached the present invention.

すなわち、本発明は、以下の発明に係るものである。
<1> 高麗人参(Panax ginseng)の根茎、葉部及び茎部の1種以上から選択される部位の加工物を有効成分として含有する若齢者学習能力向上のための経口組成物。
<2> 前記加工物が、蒸煮した根茎の乾燥物の粉砕物又は抽出物である<1>に記載の経口組成物。
<3> 形態が、錠剤状、粉末状、液状、顆粒状又はカプセル状である<1>又は<2>に記載の経口組成物。
<4> 蒸煮した根茎の乾燥物の抽出物及びブドウ糖を含有し、顆粒状である<3>に記載の経口組成物。
<5> <1>から<4>のいずれかに記載の経口組成物を含有する機能性食品。
That is, the present invention relates to the following inventions.
<1> An oral composition for improving learning ability of young people, comprising as an active ingredient a processed product of a site selected from one or more of rhizomes, leaves and stems of ginseng (Panax ginseng).
<2> The oral composition according to <1>, wherein the processed product is a pulverized product or an extract of a dried steamed rhizome.
<3> The oral composition according to <1> or <2>, which is in the form of a tablet, a powder, a liquid, a granule, or a capsule.
<4> The oral composition according to <3>, which contains an extract of a dried steamed rhizome and glucose and is granular.
<5> A functional food containing the oral composition according to any one of <1> to <4>.

<1A> <1>から<4>のいずれかに記載の経口組成物を、若齢者に経口投与して学習能力を向上させる方法(但し、ヒトに対する医療行為を除く。)。
<2A> 対象となる若齢者が、10歳以上20歳以下である<1A>に記載の方法。
<1A> A method for improving the learning ability by orally administering the oral composition according to any one of <1> to <4> to a young person (however, excluding medical practice for humans).
<2A> The method according to <1A>, wherein the target young person is 10 to 20 years old.

本発明によれば、若齢者に対する学習能力向上効果が認められる経口組成物が提供される。   ADVANTAGE OF THE INVENTION According to this invention, the oral composition which the learning ability improvement effect with respect to a young person is recognized is provided.

ベントン視覚記銘検査の図版例である。It is an illustration example of a Benton visual memorization inspection. ベントン視覚記銘検査における摂取前・摂取後の平均点数である。The average score before and after ingestion in the Benton visual memorization test. 内田クレベリン検査の用紙例である。It is an example of a paper for Uchida Kleberin test. 内田クレベリン検査の計算課題における摂取前・摂取後の平均正答数である。It is the average number of correct answers before and after ingestion in the calculation task of the Uchida-Kleberin test. TK式田中AB知能検査の6つの問題領域である。There are six problem areas of the TK Tanaka AB intelligence test. TK式田中AB知能検査における摂取前・摂取後の平均知能偏差値である。It is the average intelligence deviation value before and after ingestion in the TK Tanaka AB intelligence test.

以下、本発明について例示物等を示して詳細に説明するが、本発明は以下の例示物等に限定されるものではなく、本発明の要旨を逸脱しない範囲において任意に変更して実施できる。   Hereinafter, the present invention will be described in detail with reference to examples and the like. However, the present invention is not limited to the following examples and the like, and can be arbitrarily modified and implemented without departing from the gist of the present invention.

本発明は、高麗人参(Panax ginseng)の根茎、葉部及び茎部の1種以上から選択される部位の加工物を有効成分として含有とする若齢者学習能力向上のための経口組成物(以下、「本発明の経口組成物」と記載する。)に関する。   The present invention relates to an oral composition for improving learning ability of young people, comprising a processed product of a site selected from one or more of rhizomes, leaves and stems of ginseng (Panax ginseng) as an active ingredient ( Hereinafter, it is referred to as “the oral composition of the present invention”.).

本発明の経口組成物の原料は、ウコギ科の多年宿根草である高麗人参(Panax ginseng)の根茎、葉部又は茎部である。高麗人参は天然物であってもよく、人工的に栽培してものであってもよい。通常廃棄する高麗人参の葉部や茎部も有効利用することができるが、根茎(特には6年根)が好ましく使用される。   The raw material of the oral composition of the present invention is a rhizome, a leaf or a stem of Panax ginseng, which is a perennial rhizome of the araliaceae family. Ginseng may be a natural product or artificially cultivated. The leaves and stems of ginseng, which are normally discarded, can also be used effectively, but rhizomes (particularly, six-year roots) are preferably used.

高麗人参の使用部位(根茎、葉部又は茎部)は、前処理せずにそのまま使用することができるうえ、細断等の前処理を行って使用することもできる。   The site of use of ginseng (rhizome, leaf or stem) can be used as it is without pretreatment, or can be used after pretreatment such as shredding.

本発明において「加工物」は、高麗人参の使用部位(根茎、葉部又は茎部)に対し任意の加工処理を行ったものを意味する。
任意の加工処理としては、本発明の効果を損なわないものであるならば、適宜のものが選択でき、例えば、蒸煮処理、乾燥処理、加熱処理、抽出処理などが挙げられる。これらの処理は適宜組み合わせて行うことができる。
In the present invention, the “processed product” means a product obtained by subjecting a used portion (rhizome, leaf or stem) of ginseng to any processing.
As the optional processing, any one can be selected as long as it does not impair the effects of the present invention, and examples thereof include steaming, drying, heating, and extraction. These processes can be performed in an appropriate combination.

蒸煮処理とは対象となる原料植物(高麗人参の使用部位)を水蒸気共存下で加熱する処理である。蒸気加熱は蒸し器等の常圧で行ってもよいし、圧力釜等を利用して加圧した状態で行ってもよい。蒸煮する温度、時間は、高麗人参の使用部位や、後工程での処理方法等を考慮して適宜決定すればよいが、好適条件の一例を挙げると、常圧90℃〜100℃、8〜15時間である。   The steaming treatment is a treatment in which a target raw material plant (the site where ginseng is used) is heated in the presence of steam. The steam heating may be performed at normal pressure of a steamer or the like, or may be performed in a pressurized state using a pressure cooker or the like. The temperature and time for steaming may be appropriately determined in consideration of the site of use of ginseng, the treatment method in the subsequent step, and the like. 15 hours.

乾燥処理とは具体的には対象となる原料植物(高麗人参の使用部位)を、天日乾燥、加熱乾燥、フリーズドライ、減圧乾燥等の公知の乾燥方法で乾燥したものである。乾燥物は、使用性の観点から、通常、粉砕して粉末化され、乾燥粉砕物として使用される。粉砕方法は、特に限定はなく従来公知の粉砕器を使用すればよい。粉末の粒径は、その使用態様によって適宜決定される。   Specifically, the drying treatment is obtained by drying a target raw material plant (the site where ginseng is used) by a known drying method such as solar drying, heat drying, freeze drying, and vacuum drying. The dried product is usually pulverized and powdered from the viewpoint of usability, and used as a dried and pulverized product. The pulverizing method is not particularly limited, and a conventionally known pulverizer may be used. The particle size of the powder is appropriately determined depending on the use mode.

加熱方法は公知の方法が採用でき、加熱条件は高麗人参の含有成分の作用を損なわない範囲で任意であり、対象となる原料植物(高麗人参の使用部位)、又はこれを必要に応じて他の処理(粉砕処理、細断処理、乾燥処理等)したものを任意の方法で加熱することである。   The heating method can be a known method, and the heating conditions are arbitrary as long as the action of the components of ginseng is not impaired, and the target raw material plant (use site of ginseng) or, if necessary, other (Pulverization, shredding, drying, etc.) is heated by any method.

抽出処理とは、対象となる原料植物(高麗人参の使用部位)、又はこれを必要に応じて粉砕処理、細断処理、乾燥処理、加熱処理したものを、圧搾又は溶媒抽出するなどして、有効成分の含有量を高めた形態のものにすることを総括した概念である。具体的には高麗人参の使用部位を抽出原料として得られる抽出液、該抽出液の希釈液若しくは濃縮液、又はこれらの粗精製物若しくは精製物のいずれもが含まれる。なお、抽出液を乾燥して得られる乾燥物も、抽出物に該当するものとする。   Extraction treatment is the target raw material plant (use site of ginseng) or, if necessary, crushing, shredding, drying, heat treatment, squeezing or solvent extraction, etc., This is a general concept of providing a form in which the content of the active ingredient is increased. Specifically, the extract includes an extract obtained by using a ginseng use site as an extraction raw material, a diluent or a concentrate of the extract, or any of a crude product or a purified product thereof. Note that a dried product obtained by drying the extract is also considered to be an extract.

抽出処理に使用する抽出溶媒の具体例としては、水、メタノール、エタノール、プロパノール等の低級脂肪族アルコールが挙げられる。これらの抽出溶媒は単独又はこれら2種以上の混合物として使用することができ、2種以上の溶媒の混合液を抽出溶媒として使用する場合、その混合比は適宜調整することができる。   Specific examples of the extraction solvent used in the extraction treatment include water, lower aliphatic alcohols such as methanol, ethanol, and propanol. These extraction solvents can be used alone or as a mixture of two or more of them. When a mixture of two or more solvents is used as the extraction solvent, the mixing ratio can be appropriately adjusted.

なお、抽出溶媒には、本発明の効果を損なわない範囲で添加剤を含んでいてもよい。例えば、pH調整剤、粘度調整剤などが挙げられる。   The extraction solvent may contain an additive within a range that does not impair the effects of the present invention. For example, a pH adjuster, a viscosity adjuster and the like can be mentioned.

原料植物から抽出物を抽出する方法は特に限定されず、常法に従って行なれる。例えば、原料植物を抽出溶媒に浸漬し、室温あるいは加熱して原料植物に含まれる可溶性成分を抽出する方法が挙げられる。また、抽出物に含まれる残渣を取り除くため、濾過や遠心分離を行ってもよい。また、得られた抽出液はそのまま利用してもよいが、常法に従って、熟成、希釈、濃縮、乾燥、精製等の処理を施してもよい。   The method for extracting the extract from the raw material plant is not particularly limited, and the extraction is performed according to a conventional method. For example, there is a method in which a raw material plant is immersed in an extraction solvent, and room temperature or heating is performed to extract a soluble component contained in the raw material plant. Further, in order to remove the residue contained in the extract, filtration or centrifugation may be performed. The obtained extract may be used as it is, or may be subjected to ripening, dilution, concentration, drying, purification, etc. according to a conventional method.

高麗人参の加工物は、それぞれ単独で使用してもよいし、他の成分と混合して使用してもよい。また、異なる加工処理を行ったもの(例えば、乾燥物と抽出物)を混合して使用してもよい。   The processed products of ginseng may be used alone, or may be used as a mixture with other components. Further, those that have been subjected to different processing (for example, a dried product and an extract) may be used as a mixture.

本発明において、好適な高麗人参の加工物として、蒸煮した根茎の乾燥物の粉砕物又は抽出物が挙げられる。蒸煮して乾燥させることにより根茎に含有される成分が凝縮される。特には、根茎(好ましくは6年根)を皮つきのまま蒸煮処理後、乾燥した乾燥物(いわゆる、紅参)を粉砕した粉砕物や抽出物(エキス)が好ましい。抽出物の抽出溶媒は、好適にはエタノール、又はエタノールと水の混合溶媒である。   In the present invention, suitable processed ginseng products include pulverized or extracted dried steamed rhizomes. By steaming and drying, the components contained in the rhizome are condensed. In particular, a pulverized product or extract (extract) obtained by pulverizing a dried product (so-called red ginseng) after steaming the rhizome (preferably 6-year root) with the skin on it is preferable. The extraction solvent for the extract is preferably ethanol or a mixed solvent of ethanol and water.

本発明の経口組成物の好適な態様は、蒸煮した根茎の乾燥物の抽出物及びブドウ糖を含有し、顆粒状の経口組成物である。このような態様であれば、水やお湯に容易に溶解することができ、茶様飲料として常飲することができる。   A preferred embodiment of the oral composition of the present invention is a granular oral composition containing an extract of dried steamed rhizome and glucose. In such an embodiment, it can be easily dissolved in water or hot water, and can be regularly consumed as a tea-like beverage.

高麗人参の使用部位の加工物は、若齢者学習能力向上作用を有する。そのため、当該加工物を、本発明の経口組成物の有効成分として利用することができる。   The processed product of the used part of ginseng has an effect of improving the learning ability of young people. Therefore, the processed product can be used as an active ingredient of the oral composition of the present invention.

本明細書において、本発明の経口組成物の対象である「若齢者」とは10歳以上20歳以下の男女を意味する。より好適な対象は、13歳以上18歳以下の男女である。   As used herein, the term "young person" as a subject of the oral composition of the present invention means a man and a woman of 10 to 20 years old. More preferred subjects are men and women between 13 and 18 years of age.

また、「学習能力向上」とは、学習および/または記憶に関与する脳機能の向上を意味する。学習および/または記憶に関与する脳の作用としては例えば、注意、情報取得、情報処理、作動記憶、記憶検索、意思決定等が含まれるが、これらに限定されない。
本発明においては、学習能力向上は、ベントン視覚記銘検査、内田クレベリン検査、TK式田中AB知能検査のいずれかの検査(特にはベントン視覚記銘検査)で有意差が認められるか否かで評価するものとする。具体的には、実施例に記載する。
Further, “improvement of learning ability” means improvement of brain functions involved in learning and / or memory. Actions of the brain involved in learning and / or memory include, but are not limited to, attention, information acquisition, information processing, operational memory, memory retrieval, decision making, and the like.
In the present invention, the improvement of the learning ability depends on whether a significant difference is recognized in any of Benton visual memorization test, Uchida Kleberin test, and TK Tanaka AB intelligence test (particularly, Benton visual memorization test). Shall be evaluated. Specifically, this will be described in Examples.

本発明の経口組成物は、本発明の目的を損なわない範囲で上述の高麗人参由来の成分以外にも、脳機能の改善(例えば集中力向上、注意力向上等)に寄与する成分を配合していてもよい。   The oral composition of the present invention contains, in addition to the above-mentioned ginseng-derived components, components that contribute to improvement of brain function (for example, improvement of concentration and attention) as long as the object of the present invention is not impaired. May be.

本発明の経口組成物の形態は、特に制限されず使用する用途により適宜選択することができる。具体的には粉末状、顆粒状、カプセル状、タブレット状、グミ状、ガム状、キャンディー状、丸剤、錠剤状、棒状、板状、液状、クリーム状、軟膏状、シート状等の剤型・形態をとることができる。この中でも、錠剤状、粉末状、液状、顆粒状又はカプセル状であることが好ましい。
なお、製剤化する場合、保存や取扱いを容易にするために、薬学的に許容され得る担体やその他任意の助剤を添加することができる。
The form of the oral composition of the present invention is not particularly limited and can be appropriately selected depending on the intended use. Specifically, dosage forms such as powder, granule, capsule, tablet, gummy, gum, candy, pill, tablet, stick, plate, liquid, cream, ointment, sheet, etc.・ It can take the form. Among these, a tablet, powder, liquid, granule or capsule form is preferred.
In the case of formulation, a pharmaceutically acceptable carrier or any other auxiliary agent can be added to facilitate storage and handling.

本発明の経口組成物の摂取量は、高麗人参の使用部位、加工方法、経口組成物の形態や、対象者の年齢、性別などの個別差にもよって適宜決定すればよい。摂取量の一例は、含有するジンセノサイド(Rg1+Rb1+Rg3)量換算で、1日当たり、通常、2〜100mg程度である。   The intake of the oral composition of the present invention may be appropriately determined depending on the site of use of ginseng, the processing method, the form of the oral composition, and individual differences such as the age and gender of the subject. One example of the intake is usually about 2 to 100 mg per day in terms of the amount of ginsenoside (Rg1 + Rb1 + Rg3) contained.

本発明の経口組成物は、安全な植物由来であるため、安全で嗜好的にも優れる。そのため、日常的に経口摂取しやいように、各種の食品、飲料と混ぜて機能性食品とすることで、長期的に摂取することも容易である。ここでいう「機能性食品」とは、一般食品に加えて、健康食品、栄養補助食品、栄養機能食品、栄養保健食品等、健康の維持の目的で摂取する食品および/又は飲料を意味している。なお、機能性食品として製品化する場合には、食品に用いられる様々な添加剤、具体的には、着色料、保存料、増粘安定剤、酸化防止剤、漂白剤、防菌防黴剤、酸味料、調味料、乳化剤、強化剤、製造用剤、香料等を添加していてもよい。   Since the oral composition of the present invention is derived from a safe plant, it is safe and excellent in taste. Therefore, it is easy to ingest for a long time by mixing it with various foods and drinks to make a functional food so that it is easily taken orally on a daily basis. The term "functional food" as used herein means, in addition to general foods, health foods, dietary supplements, nutritional functional foods, nutritional health foods, and other foods and / or beverages taken for the purpose of maintaining health. I have. When commercialized as functional foods, various additives used in foods, specifically, coloring agents, preservatives, thickening stabilizers, antioxidants, bleaching agents, fungicides and fungicides , Acidulants, seasonings, emulsifiers, strengthening agents, manufacturing agents, flavors and the like may be added.

本発明の機能性食品の対象となる、食品、飲料は特に限定されるものではない。例えば、食品として、例えば、菓子,パン等の穀物の加工品が挙げられる。また、飲料としては、各種の茶類、清涼飲料水、酒類、栄養ドリンクなどが挙げられる。本発明の経口組成物は、このような食品、飲料に添加することにより、簡易に経口摂取することができる。   Foods and beverages that are targets of the functional food of the present invention are not particularly limited. For example, as the food, for example, processed cereals such as confectionery and bread are exemplified. In addition, examples of the beverage include various teas, soft drinks, alcoholic beverages, and energy drinks. The oral composition of the present invention can be easily taken orally by adding it to such foods and beverages.

本発明の経口組成物は、ヒト以外の動物に対して適用することもできる。そのため、動物用の経口組成物として使用してもよく、また、ペットフード等の動物用機能性食品へ添加することもできる。   The oral composition of the present invention can also be applied to animals other than humans. Therefore, it may be used as an oral composition for animals, or may be added to functional foods for animals such as pet food.

以下に実施例を挙げて本発明をより具体的に説明するが、本発明はこれらに限定されるものではない。   Hereinafter, the present invention will be described more specifically with reference to Examples, but the present invention is not limited thereto.

<1.試料の調製>
原料として高麗人参の根茎(6年根)を洗浄後、常圧、水蒸気共存下、95℃、10時間の条件で蒸煮処理を行った。次いで、常温で30時間、乾燥処理(通風乾燥)を行った。乾燥処理後の根茎を所定のタンクに入れ、加熱したエタノールで抽出し、ろ過で不純物を取り除くことにより、抽出物(エキス)を得た。この操作を繰り返し、得られたエキスを混合して目的とする高麗人参エキス(「ONG−90HN」と命名)を得た。この高麗人参エキスが17重量%となるように、基剤(ブドウ糖、乳糖、ビタミンCの混合物)に配合し、実施例の試料(顆粒状)を得た。
<1. Preparation of sample>
The ginseng rhizome (6-year root) was washed as a raw material, and then steamed at 95 ° C. for 10 hours under normal pressure and in the presence of steam. Next, a drying treatment (ventilation drying) was performed at room temperature for 30 hours. The rhizome after the drying treatment was put into a predetermined tank, extracted with heated ethanol, and impurities were removed by filtration to obtain an extract (extract). This operation was repeated, and the obtained extracts were mixed to obtain the desired ginseng extract (named “ONG-90HN”). This ginseng extract was blended with a base (a mixture of glucose, lactose and vitamin C) so as to be 17% by weight to obtain a sample (granular) of the example.

プラセボ品として、を含まない基剤からなる試料(顆粒状)を調製した。   As a placebo product, a sample (granular) consisting of a base containing no was prepared.

<2.評価>
実施例の試料の効果を検証するために、二重盲検ランダム化並行群間比較試験を行った。
健常な小児男女(13歳以上18歳以下)40名を対象に、比較例の試料(プラセボ茶)を摂取する20名はプラセボ群として、実施例の試料を摂取する20名は試験物群として割り当て、摂取前、摂取28日(4週間)後でのベントン視覚記銘検査、内田クレペリン検査(計算課題)及びTK式田中AB式知能検査を用いて評価した。
詳細以下の通りである。
<2. Evaluation>
In order to verify the effect of the sample of the example, a double-blind randomized parallel group comparison test was performed.
For 40 healthy males and females (13 to 18 years old), 20 subjects taking the sample of the comparative example (placebo tea) were taken as a placebo group, and 20 people taking the sample of the example were taken as a test group. Evaluation was made using the Benton visual memorization test, the Uchida-Kraepelin test (calculation task), and the TK Tanaka AB-type intelligence test before assignment, before ingestion, and 28 days (4 weeks) after ingestion.
Details are as follows.

割付けには、試験に関係ない責任者が年齢、性別で無作為抽出法を用いて、プラセボ群に20名、試験物群に20名に割付けた。
プラセボ群20名(平均年齢15.6歳:男児4名、女児16名)
試験物群20名(平均年齢15.9歳:男児4名、女児16名)
Assignments were made by a person unrelated to the study, using a random sampling method based on age and gender, to 20 persons in the placebo group and 20 persons in the test article group.
Placebo group 20 (average age 15.6 years: 4 boys, 16 girls)
Test group 20 (average age 15.9 years: 4 boys, 16 girls)

試験物群では上記実施例の試料を1日1包(3g)を、水(約100mL)に溶解し、経口摂取させた(試験物群)。また、プラセボ群では上記比較例の試料を1日1包(3g)を、水(約100mL)に溶解し、経口摂取させたプラセボ群)。試験物群、プラセボ群共に摂取期間は28日間(4週間)とした。   In the test group, one sample (3 g) of the sample of the above example was dissolved in water (about 100 mL) per day and orally taken (test group). In the placebo group, one sample (3 g) of the sample of the comparative example was dissolved in water (about 100 mL) per day, and the sample was taken orally (the placebo group). The ingestion period was 28 days (4 weeks) for both the test article group and the placebo group.

<試験結果>
(解析対象者)
試験物群、プラセボ群40名のうち、途中離脱により試験物群から3名除外したため、37名を解析対象とした。なお、摂取日数を用いて算出した摂取率は、プラセボ群91.3%(n=20)、試験物群94.7%(n=17)であった。
<Test results>
(Analyzer)
Of the 40 test article groups and the placebo group, 3 were excluded from the test article group due to withdrawal halfway, and 37 were analyzed. The intake rate calculated using the number of intake days was 91.3% (n = 20) in the placebo group and 94.7% (n = 17) in the test substance group.

(評価1)ベントン視覚記銘検査
ベントン視覚記銘検査は、視覚による記憶検査である。被験者には数種類の無意味図形が描かれたカード(図1の例参照)を10秒見せて覚えてもらい、その後カードを伏せて、白い紙に図形の形・位置・大きさなどを出来るだけ正確に描くよう指示した。カードは10枚あり、ほぼ誤りなく描かれた場合に1点を付与し、合計10点満点で成績をつけた。同レベルに設定した検査が3セット(それぞれA、B、C)準備されており、摂取前にA、摂取後にBを実施することで、出来るだけ試験ごとによる練習の効果を排除するようにした。
表1にベントン視覚記銘検査における点数を各群の摂取前後で比較した結果を示した。プラセボ群では摂取前後の比較に有意な差は認められなかった。一方、試験物群においては摂取後の点数が摂取前よりも有意に高い傾向が認められた(p<0.1)。
また、表2にプラセボ群と試験物群で比較した結果を示した。プラセボ群と試験物群の比較では、有意な差は認められなかった(図2)。

(Evaluation 1) Benton visual memorization inspection Benton visual memorization inspection is a visual memory inspection. The subject was shown a card with several meaningless figures drawn on it (see the example in Fig. 1) for 10 seconds and remembered, then turned down the card and made the shape, position and size of the figure on white paper as much as possible. Instructed to draw accurately. There were 10 cards, and if they were drawn with almost no errors, they were awarded one point, and scored a total of ten points. Three sets of tests (A, B, and C, respectively) set at the same level are prepared, and by performing A before intake and B after intake, the effect of practice by each test is eliminated as much as possible. .
Table 1 shows the results of comparing the scores in the Benton visual memorization test before and after ingestion of each group. No significant difference was observed in the placebo group before and after ingestion. On the other hand, in the test article group, scores after ingestion tended to be significantly higher than before ingestion (p <0.1).
Table 2 shows the results of comparison between the placebo group and the test article group. No significant difference was observed between the placebo group and the test article group (FIG. 2).

ベントン視覚記銘検査において、プラセボ群では摂取前後の比較に有意な差は認められなかった。一方、試験物群では、摂取後の点数が摂取前よりも有意に高い傾向が認められた。また、プラセボ群では摂取後に平均点数が0.40の下降を示し、試験物群では摂取後に0.71の上昇が示されたことから、実施例1の試料を摂取することで記憶力を向上する効果がある可能性が示唆された。   In the Benton visual memorization test, no significant difference was observed in the placebo group before and after ingestion. On the other hand, in the test article group, the scores after ingestion tended to be significantly higher than before ingestion. In addition, the placebo group showed a decrease in average score of 0.40 after ingestion, and the test article group showed an increase of 0.71 after ingestion. Therefore, ingestion of the sample of Example 1 improves memory ability. It was suggested that it might be effective.

(評価2)内田クレペリン検査用紙を使用した計算課題
内田クレペリン検査の用紙(図3の例参照)を使用して、簡単な一桁の足し算を10分間行い、その正答数を摂取前、摂取後で比較した。
表3に内田クレペリン検査用紙を使用した計算課題における正答数を各群の摂取前後で比較した結果を示した。プラセボ群、試験物群ともに摂取後の点数は摂取前よりも有意に高い点数となった(p<0.01)。
表4に正答数をプラセボ群と試験物群で比較した結果を示した。プラセボ群と試験物群の比較においては、摂取前、摂取後ともに試験物群が有意に高い傾向が認められた(p<0.1、図4)。
(Evaluation 2) Calculation tasks using Uchida-Kraepelin test paper Using a Uchida-Kraepelin test paper (see the example in Fig. 3), perform a simple one-digit addition for 10 minutes, and calculate the number of correct answers before and after ingestion Was compared.
Table 3 shows the results of comparing the number of correct answers in the calculation task using the Uchida-Kraepelin test paper before and after ingestion of each group. Both the placebo group and the test article group had significantly higher scores after ingestion than before ingestion (p <0.01).
Table 4 shows the results of comparing the number of correct answers between the placebo group and the test article group. In the comparison between the placebo group and the test article group, the test article group tended to be significantly higher both before and after ingestion (p <0.1, FIG. 4).

内田クレペリン検査用紙を使用した計算課題において、プラセボ群、試験物群ともに摂取後の点数は摂取前よりも有意に高い値となった。プラセボ群では摂取後に平均点数が66.05の上昇を示し、試験物群では摂取後に80.36の上昇が示された。両群ともに摂取後の点数が上昇したのは、問題に対する慣れが生じたのではないかと考えられる。しかし、数値的にみると点数の上昇はプラセボ群に比べて試験物群の方が大きかったことから、試験物の摂取が計算能力にプラスの効果があるのではないかと考えられた。   In the calculation task using the Uchida-Kraepelin test sheet, the scores after ingestion of both the placebo group and the test article group were significantly higher than before ingestion. In the placebo group, the average score increased by 66.05 after ingestion, and in the test group, the average score increased by 80.36 after ingestion. The rise in scores after ingestion in both groups may indicate that they may have become accustomed to the problem. However, numerically, the increase in score was greater in the test group than in the placebo group, suggesting that ingestion of the test sample might have a positive effect on computational ability.

(評価3)TK式田中AB式知能検査
言語式(A式)と非言語式(B式)を併用し、総合的に知能が測定できる知能検査である。この検査は6つの問題領域(図5参照)からなっており、易しい問題から難しい問題まで、幅広い問題で構成されている。また問題の配列が螺旋式となっているため、測定誤差が少ない検査となっている。この検査を25分間行った。
表5にTK式田中AB式知能検査における知能偏差値を各群の摂取前後で比較した結果を示した。プラセボ群、試験物群ともに摂取後の知能偏差値は摂取前よりも有意に高い点数が認められた(p<0.01、図6)。
(Evaluation 3) TK-type Tanaka AB-type intelligence test This is an intelligence test in which intelligence can be measured comprehensively by using both linguistic (A) and non-linguistic (B) expressions. This test consists of six problem areas (see FIG. 5), and consists of a wide range of problems, from easy to difficult. In addition, since the array in question is of a spiral type, the inspection has a small measurement error. This inspection was performed for 25 minutes.
Table 5 shows the results of comparison of the intelligence deviation values in the TK Tanaka AB intelligence test before and after ingestion of each group. In both the placebo group and the test article group, scores of the intelligence deviation after ingestion were significantly higher than before ingestion (p <0.01, FIG. 6).

表6に問題領域別の粗点を摂取前後で比較した結果を示した。プラセボ群では、問題A,B,C,D,Eにおいて摂取後は摂取前よりも有意に高い点数となった(p<0.01)が、問題F(数学的能力)においては摂取前後に有意な差は認められなかった。試験物群では、問題A,B,C,D,Eにおいて摂取後は摂取前よりも有意に高い点数となった(p<0.01)。問題F(数学的能力)においても摂取後は摂取前よりも有意に高い点数となった(p<0.05)。   Table 6 shows the results of comparing the rough score for each problem area before and after ingestion. In the placebo group, scores were significantly higher after ingestion in questions A, B, C, D and E than before ingestion (p <0.01), but in question F (mathematical ability) before and after ingestion No significant difference was found. In the test article group, the scores of the questions A, B, C, D, and E were significantly higher after ingestion than before ingestion (p <0.01). Question F (mathematical ability) also scored significantly higher after ingestion than before ingestion (p <0.05).

表7に知能偏差値をプラセボ群と試験物群で比較した結果を示した。プラセボ群と試験物群の知能偏差値の比較では、有意な差は認められなかった。
表8に問題領域別の粗点をプラセボ群と試験物群で比較した結果を示した。摂取前の問題C(言語的関係理解)において試験物群が有意に低い点数となった(p<0.05)。摂取後のプラセボ群と試験物群では、全ての問題において有意な差は認められなかった。
Table 7 shows the results of comparing the intelligence deviation values between the placebo group and the test article group. No significant difference was found in the comparison of the intelligence deviation between the placebo group and the test article group.
Table 8 shows the results of comparison of the rough points in each problem area between the placebo group and the test article group. The test group scored significantly lower in Question C (linguistic relationship understanding) before ingestion (p <0.05). There was no significant difference between the placebo group and the test article group after ingestion in all problems.

TK式田中AB式知能検査において、プラセボ群、試験物群ともに摂取後の知能偏差値は摂取前よりも有意に高い値となった。プラセボ群では摂取後に知能偏差値が9.05の上昇を示し、試験物群では摂取後に11.18の上昇が見られた。両群ともに摂取後の点数が上昇したのは、問題に対する慣れが生じたのではないかと考えられる。しかし、数値的にみると知能偏差値の上昇はプラセボ群に比べて試験物群の方が大きかったことから、試験物の摂取が知能検査問題にプラスの効果があるのではないかと考えられた。問題領域別の粗点を摂取前後で比較すると、問題A,B,C,D,Eにおいてはプラセボ群、試験物群ともに摂取後は摂取前よりも有意に高い点数となった。問題F(数学的能力)に関して、プラセボ群では摂取前後に有意な差はみられなかったが、試験物群では摂取後は摂取前よりも有意に高い点数となった。このことから、試験物の摂取が特に数学的能力に対してプラスの効果があるのではないかと考えられた。また、問題領域別にプラセボ群と試験物群で比較すると、問題C(言語的関係理解)において摂取前はプラセボ群が有意に高い点数となったが、摂取後には有意な差は認められなかった。   In the TK Tanaka AB intelligence test, the intellectual deviation after ingestion of both the placebo group and the test article group was significantly higher than before ingestion. The placebo group showed an increase in intelligence deviation of 9.05 after ingestion, and the test group showed an increase of 11.18 after ingestion. The rise in scores after ingestion in both groups may indicate that they may have become accustomed to the problem. However, numerically, the increase in intelligence deviation was greater in the test group than in the placebo group, suggesting that ingestion of the test sample might have a positive effect on the intelligence test problem. . Comparing the rough scores of the problem areas before and after ingestion, the scores in the placebo group and the test article group in the questions A, B, C, D, and E were significantly higher after ingestion than before ingestion. Regarding question F (mathematical ability), no significant difference was observed before and after ingestion in the placebo group, but in the test group, the score was significantly higher after ingestion than before ingestion. This suggests that ingestion of the test article may have a positive effect especially on mathematical performance. When the placebo group and the test article group were compared according to the problem area, the placebo group had a significantly higher score in question C (linguistic relationship understanding) before ingestion, but no significant difference was observed after ingestion. .

以上の通り、ベントン視覚記銘検査の試験物群において、摂取後にスコアの有意な上昇傾向が確認された。また、内田クレペリン検査及びTK式田中AB式知能検査の試験物群においても、摂取後にスコアの有意な上昇が確認された。
以上の結果から、若齢者の高麗人参エキスの摂取が学習能力の向上効果を有すると考えられる。
As described above, in the test group of the Benton visual memorization test, a significant increase in the score after ingestion was confirmed. In the test groups of the Uchida-Kraepelin test and the TK-type Tanaka AB-type intelligence test, a significant increase in the score after ingestion was also confirmed.
From the above results, it is considered that the ingestion of ginseng extract by young people has an effect of improving learning ability.

本発明の経口組成物を摂取することにより、若齢者の学習能力向上するため、産業的に有望である。   Ingestion of the oral composition of the present invention improves the learning ability of young people, and is therefore industrially promising.

Claims (7)

高麗人参(Panax ginseng)の根茎、葉部及び茎部の1種以上から選択される部位の加工物を有効成分として含有する若齢者学習能力向上のための経口組成物。   An oral composition for improving the learning ability of young people, comprising as an active ingredient a processed product of a site selected from at least one of rhizomes, leaves and stems of ginseng (Panax ginseng). 前記加工物が、蒸煮した根茎の乾燥物の粉砕物又は抽出物である請求項1に記載の経口組成物。   The oral composition according to claim 1, wherein the processed product is a pulverized product or an extract of a dried steamed rhizome. 形態が、錠剤状、粉末状、液状、顆粒状又はカプセル状である請求項1または2に記載の経口組成物。   The oral composition according to claim 1 or 2, wherein the form is a tablet, a powder, a liquid, a granule or a capsule. 蒸煮した根茎の乾燥物の抽出物及びブドウ糖を含有し、顆粒状である請求項3に記載の経口組成物。   The oral composition according to claim 3, wherein the oral composition contains a dried extract of steamed rhizome and glucose, and is in the form of granules. 請求項1から4のいずれかに記載の経口組成物を含有する機能性食品。   A functional food containing the oral composition according to claim 1. 請求項1から4のいずれかに記載の経口組成物を、若齢者に経口投与して学習能力を向上させる方法(但し、ヒトに対する医療行為を除く。)。   A method for improving the learning ability by orally administering the oral composition according to any one of claims 1 to 4 to a young person (however, excluding medical practice for humans). 対象となる若齢者が、10歳以上20歳以下である請求項6に記載の方法。   The method according to claim 6, wherein the target young person is 10 to 20 years old.
JP2019230367A 2018-06-18 2019-12-20 Oral composition and functional food for improving learning ability of young people Active JP7383281B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019230367A JP7383281B2 (en) 2018-06-18 2019-12-20 Oral composition and functional food for improving learning ability of young people

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018115554A JP2019218284A (en) 2018-06-18 2018-06-18 Oral composition for improving juvenile learning ability, and method for improving juvenile learning ability
JP2019230367A JP7383281B2 (en) 2018-06-18 2019-12-20 Oral composition and functional food for improving learning ability of young people

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018115554A Division JP2019218284A (en) 2018-06-18 2018-06-18 Oral composition for improving juvenile learning ability, and method for improving juvenile learning ability

Publications (2)

Publication Number Publication Date
JP2020045368A true JP2020045368A (en) 2020-03-26
JP7383281B2 JP7383281B2 (en) 2023-11-20

Family

ID=88833493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019230367A Active JP7383281B2 (en) 2018-06-18 2019-12-20 Oral composition and functional food for improving learning ability of young people

Country Status (1)

Country Link
JP (1) JP7383281B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327010A (en) * 2008-07-07 2008-12-24 吉林省宏久生物科技股份有限公司 Method for preparing amber ginseng
KR20110005144A (en) * 2009-07-09 2011-01-17 대한민국(농촌진흥청장) Pharmaceutical composition and health-food composition containing ginseng extracts having neuroprotective effects
JP2016128427A (en) * 2015-01-09 2016-07-14 株式会社アモーレパシフィックAmorepacific Corporation Composition comprising panax ginseng extract having enhanced ginsenoside content as active ingredient

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327010A (en) * 2008-07-07 2008-12-24 吉林省宏久生物科技股份有限公司 Method for preparing amber ginseng
KR20110005144A (en) * 2009-07-09 2011-01-17 대한민국(농촌진흥청장) Pharmaceutical composition and health-food composition containing ginseng extracts having neuroprotective effects
JP2016128427A (en) * 2015-01-09 2016-07-14 株式会社アモーレパシフィックAmorepacific Corporation Composition comprising panax ginseng extract having enhanced ginsenoside content as active ingredient

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
NISHIJO H. ET AL.: "RED GINSENG AMELIORATES LEARNING DEFICITS IN YOUNG RATS WITH HIPPOCAMPAL LESIONS AND AGED RATS", JAPANESE JOURNAL OF PHYSIOLOGY, vol. 53, JPN6019031448, 2003, pages 90, ISSN: 0005091526 *
NUTRITIONAL NEUROSCIENCE, vol. 4, no. 4, JPN6019040370, 31 December 2001 (2001-12-31), pages 295 - 310, ISSN: 0005091530 *
PLANTA MEDICA, vol. 59, JPN6019031455, 1993, pages 106 - 114, ISSN: 0005091528 *
PSYCHOPHARMACOLOGY, vol. (2004) Vol. 172, JPN6019031453, 25 November 2003 (2003-11-25), pages 430 - 434, ISSN: 0005091529 *
薬理と治療, vol. 12, no. 4, JPN6019031450, April 1984 (1984-04-01), pages 30 - 36, ISSN: 0005091527 *

Also Published As

Publication number Publication date
JP7383281B2 (en) 2023-11-20

Similar Documents

Publication Publication Date Title
KR101498780B1 (en) Composition for preventing or treating hangover
EP3193898B1 (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
KR102134385B1 (en) Composition for Respiratory Symptoms Containing Red Ginseng Extract
KR101102578B1 (en) Method producing functional vinegar picked egg and functional vinegar picked egg produced by the same method
KR101687982B1 (en) Composition for improving sexual functionality having effects of increasing of the number of sperm and protection of environmental hormone and manufacturing method thereof
KR20150005430A (en) Composition for relieving premenstrual syndrome and menstrual pain
KR20160103758A (en) A manufacturing method for red ginseng with enriched ginsenoside and a slice of red ginseng thereof
KR100549089B1 (en) A Health Care Composition for treating or preventing intestinal disease and constipation
JP2018521003A (en) Composition for prevention or treatment of benign prostatic hyperplasia containing sykunshi extract
KR101814296B1 (en) Antioxidative tea composition comprising sweet potato peel
CN105412277A (en) Traditional Chinese medicinal composition of lipid-lowering tea and application of traditional Chinese medicinal composition
KR101394358B1 (en) Health composition relieving alcohol hangover
JP2010275288A (en) Functional composition for preventing and improving hangover, food and food additive containing the same
JP6844857B2 (en) A skin moisturizing composition containing acacia bark-derived products
JP5969529B2 (en) Anti-inflammatory agent
JP2018506524A (en) Composition for prevention, amelioration or treatment of burnout syndrome
JP7383281B2 (en) Oral composition and functional food for improving learning ability of young people
KR20190102493A (en) A pill for functional food comprising Protaetia brevitarsis seulensis and manufacturing method therof
JP2019218284A (en) Oral composition for improving juvenile learning ability, and method for improving juvenile learning ability
KR100506824B1 (en) Crude Drug Compositions for treating or preventing intestinal disease and constipation
KR100972023B1 (en) Composition for preventing or improving the brain ischemia disease containing extract of chrysanthemum indicum var. albescens
KR20150092400A (en) Bread comprising the extract of Cirsium setidens or Aster scaber for protection of brain neuronal cells and method of preparing the same
KR102343245B1 (en) Composition for preventing, ameliorating or treating atopic dermatitis comprising Chrysanthemum indicum L. oil extract as effective component
JP6141071B2 (en) Skin moisture increasing agent
JP2004323439A (en) Composition for ameliorating blood viscosity

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210615

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20210714

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220719

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20221116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230214

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230414

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230724

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231017

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231031

R150 Certificate of patent or registration of utility model

Ref document number: 7383281

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150